CODA Biotherapeutics Funding: $63M Raised, Series A (2021)
CODA Biotherapeutics is based in South San Francisco. It has raised $63M in total funding. Latest round: Series A.
CODA Biotherapeutics funding overview
CODA Biotherapeutics is based in South San Francisco. CODA Biotherapeutics has raised $63M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2021. The round record for CODA Biotherapeutics runs through 2021; nothing later has been disclosed. Investors on record include MPM Capital, Versant Ventures, Astellas Venture Management, National Institute OF Neurological Disorders And Stroke. 4 distinct backers are named across the disclosed rounds.
CODA Biotherapeutics at a glance
Total raised
$63M
Latest round
Series A
Latest round date
December 2021
Headquarters
South San Francisco
Notable investors
MPM Capital, Versant Ventures, Astellas Venture Management, National Institute OF Neurological Disorders And Stroke
Frequently asked about CODA Biotherapeutics funding
How much has CODA Biotherapeutics raised?
CODA Biotherapeutics has raised $63M in total disclosed funding across the rounds on record.
Who has invested in CODA Biotherapeutics?
MPM Capital, Versant Ventures, Astellas Venture Management, National Institute OF Neurological Disorders And Stroke are named among the investors backing CODA Biotherapeutics.
What was the latest CODA Biotherapeutics funding round?
The most recent disclosed round is a Series A, announced in December 2021.
Where is CODA Biotherapeutics based?
CODA Biotherapeutics is based in South San Francisco.
When did CODA Biotherapeutics last raise?
The last disclosed CODA Biotherapeutics round closed in December 2021 at Series A.
We update the CODA Biotherapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in South San Francisco and their backers are listed below.
